Boundless Bio, Inc.
Boundless Bio develops oncology therapeutics for oncogene amplified tumors.
8-KAug 28Latest SEC filing, period to Aug 28
Aug 28Latest story
August 2026
Sign inSign inBoundless Bio develops oncology therapeutics for oncogene amplified tumors.